Synopsis
Interpret ESR, CRP and related inflammatory markers as context-dependent trends, recognising discordance, non-rheumatic causes and the conditions in which a normal result cannot safely close the diagnosis.
- CRP is a hepatic acute-phase protein that changes relatively quickly; ESR is an indirect sedimentation measure affected by fibrinogen, immunoglobulins, red-cell characteristics, age and pregnancy.
- Neither test is specific for rheumatic disease: infection, cancer, trauma, tissue injury and obesity can raise inflammatory markers.
- Normal markers do not exclude rheumatoid arthritis, axial spondyloarthritis, giant-cell arteritis, infection or connective-tissue disease when the phenotype remains convincing.
- ESR may remain raised with anaemia, paraproteinaemia, renal disease or older age even when CRP and clinical inflammation are modest.
- An isolated high CRP with relatively normal ESR may reflect early acute inflammation because CRP responds faster, but timing and laboratory ranges matter.
- Use trends only when the same clinical question persists; repeating markers without examining the patient can create false reassurance or unexplained surveillance.
- Disease activity scores may incorporate markers, but patient pain and comorbidity can diverge from synovitis; combine scores with examination and function.
- A very high or unexpectedly persistent inflammatory response should reopen infection, malignancy and tissue injury rather than automatically prompting more immunosuppression.
Key red flags
A rapid CRP increase with systemic illness supports an acute inflammatory or infectious process and should be interpreted alongside cultures, imaging and organ function.
Investigation priorities
Quantify a rapidly responsive acute-phase signal and follow a defined inflammatory trajectory.
Management branches
Septic joint, threatened vision, systemic vasculitis or spinal infection remains clinically plausible regardless of ESR or CRP.
- Perform urgent clinical and organ assessment, obtain the definitive samples or imaging and involve the responsible specialist without waiting for repeat markers.
- Begin time-critical treatment according to the relevant pathway when delay risks joint, vision, neurological or organ loss.
- Use serial markers only as one component of response alongside physiology, examination, microbiology, imaging and organ function.